Abstract:Background Several pioneering studies have provided evidence for the introduction of universal pulse oximetry screening for critical congenital heart disease. However, whether the benefits of screening reported in studies from high-income countries would translate with similar success to low-income countries is unknown. We assessed the feasibility and reliability of pulse oximetry plus clinical assessment for detection of major congenital heart disease, especially critical congenital heart disease, in China.Methods We did a pilot study at three hospitals in Shanghai to assess the accuracy of pulse oximetry plus clinical assessment for detection of congenital heart disease. We made a data collection plan before recruitment. We then undertook a large, prospective, and multicentre screening study in which we screened all consecutive newborn babies (aged 6-72 h) born at 18 hospitals in China between Aug 1, 2011, and Nov 30, 2012. Newborn babies with positive screen results (either an abnormal pulse oximetry or abnormal clinical assessment) were referred for echocardiography within 24 h of screening. We identified false-negative results by clinical follow-up and parents' feedback. We calculated sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios for pulse oximetry alone, and in combination with clinical assessment, for detection of major and critical congenital heart disease.Findings In the pilot study, 6785 consecutive newborn babies were screened; 46 of 49 (94%) cases of asymptomatic major congenital heart disease and eight of eight (100%) cases of asymptomatic critical disease were detected by pulse oximetry and clinical assessment. In the prospective multicentre study, we screened 122 738 consecutive newborn babies (120 707 asymptomatic and 2031 symptomatic), and detected congenital heart disease in 1071 (157 critical and 330 major). In asymptomatic newborn babies, the sensitivity of pulse oximetry plus clinical assessment was 93 2% (95% CI 87 9-96 2) for critical congenital heart disease and 90 2% (86.4-93.0) for major disease. The addition of pulse oximetry to clinical assessment improved sensitivity for detection of critical congenital heart disease from 77.4% (95% CI 70 0-83.4) to 93 2% (87 9-96.2). The false-positive rate for detection of critical disease was 2.7% (3298 of 120 392) for clinical assessment alone and 0 3% (394 of 120 561) for pulse oximetry alone.Interpretation Pulse oximetry plus clinical assessment is feasible and reliable for the detection of major congenital heart disease in newborn babies in China. This simple and accurate combined method should be used in maternity hospitals to screen for congenital heart disease.Funding Key Clinical Research Project sponsored by Ministry of Health, Shanghai Public Health Three-Year Action Plan sponsored by Shanghai Municipal Government, and National Basic Research Project of China.

Screening for Congenital Heart Defects: Diversified Strategies in Current China

Pediatric Heart Surgery in China: Progress and Challenges

Epidemiology, Prenatal Diagnosis, and Neonatal Outcomes of Congenital Heart Defects in Eastern China: a Hospital-Based Multicenter Study

Study on Diagnostic Performance of Fetal Intelligent Navigation Echocardiography for Congenital Heart Defect

Geographical and Socioeconomic Factors Influence the Birth Prevalence of Congenital Heart Disease: A Population-based Cross-sectional Study in Eastern China

Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China

Progresses of Screening for Congenital Heart Defects in Neonates

The Establishment of Appropriate Technology and Its Application for Screening,diagnosing and Evaluating of Congenital Heart Disease in Children Aged 0-3 Years in the Rural Areas

Pulse Oximetry with Clinical Assessment to Screen for Congenital Heart Disease in Neonates in China: a Prospective Study

A "twelve-section ultrasonic screening and diagnosis method" and management system for screening and treating neonatal congenital heart disease at the grassroots level in Tang County, Hebei Province, China

Neonatal screening for congenital hypothyroidism and phenylketonuria in China

Application Value of Fetal Heart Ultrasound Intelligent Navigation Technique in Display of Key Diagnostic Elements in Rapid Screening Views of Fetal Echocardiography

[Retrospective Study on Neonatal Screening for Congenital Hypothyroidism and Phenylketonuria in China in the Past 22 Years].

Prevalence of Congenital Heart Disease at Live Birth in China.

The 'Ironclad friendship' of China-Cambodia, lays the first step in the foundation of early diagnosis and treatment of asymptomatic congenital heart Defects- A multi-national screening and intervention project, 2017-2020

[Specification for Genetic Diagnosis of Congenital Heart Disease].

Establishment and Implementation of Neonatal Screening Program for Congenital Heart Disease Based on Echocardiographic Confirmation

A Hospital-Based Study on Congenital Heart Defects — Haidian District, Beijing Municipality, China, 2013–2022

Feasibility of constructing a screening-evaluating-intervention system of congenital heart disease in Changzhou city

Prenatal Diagnosis of Congenital Heart Diseases by Fetal Echocardiography in Second Trimester: a Chinese Multicenter Study.

Clinical Screening of Congenital Heart Disease in Neonates: a Literature Review on Five Studies